首页> 外文期刊>PLoS One >A convenient approach to synthesize substituted 5-Arylidene-3- m- tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study
【24h】

A convenient approach to synthesize substituted 5-Arylidene-3- m- tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study

机译:通过使用吗啉作为催化剂的一种方便的方法合成取代的5-亚亚胺-3-甲基噻唑烷-2,4-二乙醚及其理论研究

获取原文
           

摘要

Thiazolidinediones are very important and used as a drug for the treatment of type 2 diabetes. Here, we report a convenient approach to synthesis 3-m-tolyl-5-arylidene-2,4-thiazolidinediones (TZDs) derivatives 7a-e in two steps with moderate to good yield using morpholine as a catalyst. All the structures were confirmed by their spectral IR, 1 H NMR and 13 C NMR data. The anti-diabatic activity of all synthesized molecules is evaluated by docking with peroxisome proliferator-activated receptor-γ (PPARγ). Preliminary flexible docking studies reveals that our compounds 7a , 7d and 7e showed better binding affinity with the protein and could be a potential candidate for the treatment of type 2 diabetes in near future.
机译:噻唑烷二酮非常重要,用作治疗2型糖尿病的药物。 在这里,我们报告了一种方便的方法,以合成3-M-甲苯-5-亚亚亚氮-2,4-噻唑烷二氧化乙烯(TZDS)衍生物7A-E的两步,其使用吗啉作为催化剂中等至良好的产量。 通过其光谱IR,1 H NMR和13 C NMR数据证实所有结构。 通过用过氧化物酶体增殖物激活的受体-γ(PPARγ)对接来评估所有合成分子的抗糖尿病活性。 初步柔性对接研究表明,我们的化合物7a,7d和7e与蛋白质显示出更好的结合亲和力,并且可以是在不久的将来治疗2型糖尿病的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号